Tamilvanan Shunmugaperumal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tamilvanan Shunmugaperumal has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
Syed Nazrin Ruhina Rahman
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Guwahati, India
14 shared publicationsAbhinab Goswami
National Institute of Pharmaceutical Education and Research- Guwahati
13 shared publicationsDatta Maroti Pawde
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Guwahati, India; Department of Pharmaceutics, School of Pharmacy & Technology Management, SVKM'S Narsee Monjee Institute of Management Studies (NMIMS), Shirpur, Maharashtra, India
9 shared publicationsAmoolya Sree
8 shared publicationsPayel Chakraborty
6 shared publicationsAnkita Das
4 shared publications
Latest Publications
- Open Access
- 10 October 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
Identification of key genes and pathways in corneal neovascularisation: integrating text mining and bioinformatic analysis
- 10 October 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
Open AccessIdentification of key genes and pathways in corneal neovascularisation: integrating text mining and bioinformatic analysis
- Open Access
- 14 November 2025
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 15  (6)
Natural Deep Eutectic Solvents: Green Chemistry Solutions for Pharmaceutical Applications
Natural Deep Eutectic Solvents (NADES) are an environmentally acceptable and promising green alternative to traditional organic solvents in the pharmaceutical industry. Composed of naturally derived, biodegradable components such as sugars, amino acids, and organic acids, NADES offer significant advantages in terms of safety, sustainability, and tunable properties. These solvents exhibit low volatility, high thermal stability, and excellent solubilization capabilities for both polar and non-polar compounds, making them ideal for drug extraction, formulation, and delivery. Unlike traditional solvents, NADES can enhance the solubility and bioavailability of poorly water-soluble drugs, reduce the need for harmful excipients, and support eco-friendly manufacturing processes. Recent studies have also highlighted their potential in improving the stability and therapeutic efficacy of active pharmaceutical ingredients (APIs). Furthermore, their biocompatibility and minimal toxicity expand their applicability in areas such as topical formulations and nanocarriers. Despite their growing promise, challenges such as standardization, regulatory acceptance, and large-scale production need to be addressed. This review discusses the composition, preparation, and pharmaceutical applications of NADES, emphasizing their role in advancing green chemistry principles. Overall, NADES represent a transformative approach for sustainable pharmaceutical development, aligning with environmental goals while maintaining high-performance standards in drug design and delivery.
- 14 November 2025
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 15  (6)
Open AccessNatural Deep Eutectic Solvents: Green Chemistry Solutions for Pharmaceutical Applications
Natural Deep Eutectic Solvents (NADES) are an environmentally acceptable and promising green alternative to traditional organic solvents in the pharmaceutical industry. Composed of naturally derived, biodegradable components such as sugars, amino acids, and organic acids, NADES offer significant advantages in terms of safety, sustainability, and tunable properties. These solvents exhibit low volatility, high thermal stability, and excellent solubilization capabilities for both polar and non-polar compounds, making them ideal for drug extraction, formulation, and delivery. Unlike traditional solvents, NADES can enhance the solubility and bioavailability of poorly water-soluble drugs, reduce the need for harmful excipients, and support eco-friendly manufacturing processes. Recent studies have also highlighted their potential in improving the stability and therapeutic efficacy of active pharmaceutical ingredients (APIs). Furthermore, their biocompatibility and minimal toxicity expand their applicability in areas such as topical formulations and nanocarriers. Despite their growing promise, challenges such as standardization, regulatory acceptance, and large-scale production need to be addressed. This review discusses the composition, preparation, and pharmaceutical applications of NADES, emphasizing their role in advancing green chemistry principles. Overall, NADES represent a transformative approach for sustainable pharmaceutical development, aligning with environmental goals while maintaining high-performance standards in drug design and delivery.
- 11 June 2025
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 16  (8) , 713-732
Intratympanic injection of emulsion-like dispersions to co-deliver cinnarizine and morin hydrate-lipoid E80 complex in a rabbit inner ear model
Drug delivery to perilymph after crossing the round window membrane is paramount important for inner ear disease management. Intratympanic (IT) injection of emulsion-like dispersions augments cinnarizine (CNZ) and morin hydrate (MH)-Lipoid E80 complex permeation into perilymph in a healthy rabbit inner ear model. A Box-Behnken design (BBD) followed by artificial neural network (ANN)-linked Levenberg - Marquardt (LM) algorithm was used for optimizing the injection formula. Immediately after 30-120 minutes post-IT injections, the concentration levels of CNZ and MH in both perilymph and plasma were monitored. The ANN-linked LM algorithm displayed lower prediction and mean squared errors as well as higher correlation coefficient values for all responses when compared to the corresponding values shown by BBD. The IT injections possessed 156.8 ± 8.5 nm mean particle size, 42.70 ± 4.20 mV zeta potential, >98% CNZ and MH release within 10-20 minutes dissolution in pH 7.4 artificial perilymph solution, >97.26% cell viability in MTT assay and near normal histopathology. The 63.07 ± 23.62 µg/ml CNZ and 82.51 ± 8.33 µg/ml MH were attained in perilymph at 60 minutes post-IT injections. The IT-injected formulation can be used to co-deliver two drugs in perilymph for managing inner ear diseases.
- 11 June 2025
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 16  (8) , 713-732
Intratympanic injection of emulsion-like dispersions to co-deliver cinnarizine and morin hydrate-lipoid E80 complex in a rabbit inner ear model
Drug delivery to perilymph after crossing the round window membrane is paramount important for inner ear disease management. Intratympanic (IT) injection of emulsion-like dispersions augments cinnarizine (CNZ) and morin hydrate (MH)-Lipoid E80 complex permeation into perilymph in a healthy rabbit inner ear model. A Box-Behnken design (BBD) followed by artificial neural network (ANN)-linked Levenberg - Marquardt (LM) algorithm was used for optimizing the injection formula. Immediately after 30-120 minutes post-IT injections, the concentration levels of CNZ and MH in both perilymph and plasma were monitored. The ANN-linked LM algorithm displayed lower prediction and mean squared errors as well as higher correlation coefficient values for all responses when compared to the corresponding values shown by BBD. The IT injections possessed 156.8 ± 8.5 nm mean particle size, 42.70 ± 4.20 mV zeta potential, >98% CNZ and MH release within 10-20 minutes dissolution in pH 7.4 artificial perilymph solution, >97.26% cell viability in MTT assay and near normal histopathology. The 63.07 ± 23.62 µg/ml CNZ and 82.51 ± 8.33 µg/ml MH were attained in perilymph at 60 minutes post-IT injections. The IT-injected formulation can be used to co-deliver two drugs in perilymph for managing inner ear diseases.
- 7 November 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 102
Intratympanic injections made from eutectic liquid (camphor and menthol)-based oil-less emulsions containing morin hydrate-lipoid E80 complex: An approach to augment drug permeation into inner ear region in a healthy rabbit model
- 7 November 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 102
Intratympanic injections made from eutectic liquid (camphor and menthol)-based oil-less emulsions containing morin hydrate-lipoid E80 complex: An approach to augment drug permeation into inner ear region in a healthy rabbit model
- 30 April 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19  (12) , 1035-1050
Studies on cationic ocular emulsions containing bipartitioned oil droplets to codeliver cyclosporin A and etodolac
Background: To prepare ocular emulsions containing bipartitioned oil droplets to entrap cyclosporin A (0.05% w/w) and etodolac (0.2% w/w) by using castor, olive and silicon oils. Methods: The physi...
- 30 April 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19  (12) , 1035-1050
Studies on cationic ocular emulsions containing bipartitioned oil droplets to codeliver cyclosporin A and etodolac
Background: To prepare ocular emulsions containing bipartitioned oil droplets to entrap cyclosporin A (0.05% w/w) and etodolac (0.2% w/w) by using castor, olive and silicon oils. Methods: The physi...
- 18 December 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 258  (Pt 1) , 128776
From co-delivery to synergistic anti-inflammatory effect: Studies on chitosan-stabilized Janus emulsions having chloroquine phosphate and flavopiridol in Complete Freund's Adjuvant induced arthritis rat model
- 18 December 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 258  (Pt 1) , 128776
From co-delivery to synergistic anti-inflammatory effect: Studies on chitosan-stabilized Janus emulsions having chloroquine phosphate and flavopiridol in Complete Freund's Adjuvant induced arthritis rat model
- 28 November 2023
- Published by Elsevier in Fluid Phase Equilibria
- Vol. 578
Solubility of cinnarizine in natural deep eutectic solvent (camphor + menthol) and correlation with different solubility models
- 28 November 2023
- Published by Elsevier in Fluid Phase Equilibria
- Vol. 578
Solubility of cinnarizine in natural deep eutectic solvent (camphor + menthol) and correlation with different solubility models